Autosomal-recessive hyper-IgE syndrome (AR-HIES) is a combined immunodeficiency recently found to be associated with mutations of DOCK8. Clinically, this disorder is characterized beside recurrent bacterial complications, in particular by an unusual susceptibility to extensive cutaneous viral complications and by a high risk for squamous cell carcinoma. Here, we report on lasting control over the disorder in two patients by hematopoietic cell transplantation (HCT). Both patients were suffering from extensive long-lasting cutaneous viral complications, in particular from disfiguring molluscum contagiosum infections, when treated at the age of 10 and 17 years. Donors were matched unrelated, and conditioning was carried out with a combination of fludarabine, melphalan and BM-targeted radioimmunotherapy. Both patients developed stable, full donor cell chimerism, with the exception of persistent lowIgA serum levels and the exception of normal immune functions. Over the course of several months, cutaneous manifestations of viral disease resolved completely and both patients remain clinically well and free of infectious complications at 4 and 2 years, respectively, after transplantation. This represents the first report indicating HCT to be curative in patients with AR-HIES, which should be considered early before life-threatening complications develop, which include malignancies.
Introduction
The autosomal-recessive variant of hyper-IgE syndrome (AR-HIES) is a combined immunodeficiency characterized by high serum IgE levels, eosinophilia, atopy, recurrent sinopulmonary infections, recurrent staphylococcal skin infections and extensive cutaneous manifestations of frequently coexisting infections by molluscum contagiosum, human papillomavirus and HSVs. 1, 2 The disorder has recently been characterized at the molecular level by Zhang et al., who described mutations in DOCK8, a member of a family of Rho-Rac GTP-exchange factors, in 11 patients from 8 families suffering from AR-HIES. Four of the presented patients had died at the age between 13 and 21 years, three of these patients had developed squamous cell carcinoma, most likely because of persistent human papillomavirus infections. Further patients with the syndrome and mutations in DOCK8 have recently been described. 3 Previously, a homozygous mutation of TYK2 was ascribed to a single case of AR-HIES. 4 Classical hyperIgE syndrome is caused by mutations in STAT3, occurs either sporadic or with autosomal-dominant inheritance and is characterized by mainly bacterial infectious complications, as well as by nonimmunological abnormalities, including skeletal and dental abnormalities. [5] [6] [7] These latter abnormalities were not observed in DOCK8-deficient patients, whereas persistent lymphocytopenia, due to low CD4 þ and CD8 þ T cells, as well as diminished lymphocyte functions, were prominent findings. Although these immunological abnormalities likely are causative for the profound susceptibility to viral infections, a direct role of DOCK8 deficiency in the etiology of the exceptional susceptibility to cutaneous viral disease is not ruled out.
Here, we report on two patients with AR-HIES and DOCK8 mutations undergoing successful hematopoietic cell transplantation (HCT), leading to lasting resolution of viral complications.
Materials and methods
Informed consent for diagnostic tests and approval for HCT were obtained from the parents of the patients and from the adolescent patients in accordance with the Declaration of Helsinki.
Conditioning in both patients consisted of the same investigational protocol, which was approved by the local ethics committee, using radioimmunotherapy with Yttrium 90-labeled CD66 Ab, providing targeted radiation to the BM at a dosage of 16 Gy (day À14), in combination with fludarabine (40 mg/m 2 /day on days À7 to À4), melphalan (140 mg/m 2 /day on day À3) and antithymocyte globulin (rabbit, Genzyme, Neu-Isenburg, Germany; 10 mg/kg/day on days À3 to À1).
8 GVHD prophylaxis comprised CsA and mycophenolate. Both patients were transplanted from matched unrelated donors with molecular HLA matches at 10 of 10 loci. Patient 1 received 9 Â 10 6 cells/kg CD34 þ PBSCs with an adjusted T-cell number of 1 Â 10 7 T cells/kg; patient 2 received BM depleted of red cells because of blood group incompatibility, containing 2.4 Â 10 6 CD34 þ cells/ kg and 2 Â 10 7 T cells/kg.
Molecular studies
Genomic DNA of both patients was isolated and the exons of DOCK8 were amplified and sequenced. In addition, single-nucleotide polymorphism (SNP)-arrays were applied for loss of heterozygosity, copy number and deletional analyses (Genome-Wide Human SNP Array 6.0, Affymetrix, Santa Clara, CA, USA). DOCK8 expression was assessed by DOCK8 reverse transcriptase-PCR and a western blot of peripheral blood mononuclear cell.
Results and discussion
Clinical data and laboratory findings in the two patients, who were 10 and 17 years of age at the time of HCT, are summarized in Table 1 . Leading complications in both patients were recurrent bacterial sinopulmonary infections, chronic eczema and, in particular, extensive, treatmentresistant, disfiguring molluscum contagiosum, involving predominantly the periocular and periauricular area, as well as the anogenital region. Patient 1 in addition suffered from chronic autoimmune hemolytic anemia, for which he had received treatment with steroid and several infusions of anti-CD20-Ab, leading to PRs only. In patient 2, the disease was complicated by severe periodontitis, recurrent skin abscesses and chronic ulcerative herpes simplex infections involving the oral cavity and the anogenital region, in addition to extensive molluscum contagiosum infections similar as in patient 1. Laboratory findings in both patients included eosinophilia, high serum IgE and elevated IgG levels, as well as T lymphocytopenia and depressed in vitro T-cell functions.
On the basis of the recently reported DOCK8 mutations in 11 patients with similar clinical and laboratory abnormalities as observed in our two cases, genetic analyses were performed using frozen material stored before transplantation. In both cases, mutations in DOCK8 were found. Patient 1 is a compound heterozygote with one allele bearing a chromosome 9p deletion of at least 411 047 nucleotides encompassing the complete DOCK8 gene (chrom9 del 176 581-587 627; numbers indicate the limiting SNPs scored with copy number loss on the Affymetrix Genome-Wide Human SNP Array 6.0). The second allele bears a small, four-nucleotide deletion on exon 8, leading to a premature stop codon (NM_203447.3; c.880_883de-lAAAG, p.Glu295GlyfsX13) (Figure 1a) . In patient 2, PCR analysis of DOCK8 exons 1-26 yielded no amplification products, with the remaining exons showing normal sequences. The DOCK8 affecting gross deletion was confirmed by SNP Chip analysis exhibiting a homozygous loss of at least 357 597 nucleotides (chrom9 del 30 910-388 506) ( Figure 1a) .
As expected, patient 1 expressed reduced levels of DOCK8 RNA (Figure 1b) , whereas patient 2, who lost the DOCK8 regulatory region, lacked DOCK8 transcripts. In blood mononuclear cell, DOCK8 protein was not detectable in either patient (Figure 1c) .
In patient 1, the transplant course was uncomplicated, with absence of GVHD and an uneventful hematological reconstitution (see Table 1 ). Beside one febrile episode in aplasia, he suffered from transient exacerbation of sinusitis at several weeks after HCT and developed mild herpes zoster after cessation of acyclovir prophylaxis at 3 months after transplantation. Complete donor cell chimerism was noted on day þ 26 and ever since (last analysis 32 months post-HCT). Immune functions have completely normalized except persistent low-serum IgA levels.
Patient 2 in contrast had a stormy transplant course. She developed severe oral mucositis and worsening of ulcerative lesions of the anogenital region. On day 16, she became somnolent and on carrying out nuclear magnetic resonance imaging, several fresh brain abscesses were disclosed. Because of multiple dentogenic foci as the likely cause, all teeth were extracted. Antibiotic therapy was given for almost 1 year and the patient recovered completely and without neurological sequelae from this complication. At day 70, an acute EBV infection developed, manifested by bilateral painful swelling of cervical nodes, parotitis, headaches and high fever, from which the patient recovered after treatment with anti-CD20 MoAb. She was discharged from the hospital on day 110 after transplantation. Full donor chimerism was shown by XX/XY FISH on all occasions. Immunological functions normalized, with the exception of subnormal IgA serum levels.
Cutaneous viral infections, including chronic molluscum contagiosum, completely resolved in both patients. Interestingly, at several weeks after HCT, lesions of molluscum contagiosum became more florid and prominent, which was followed by slow healing and sustained clearance of all lesions in both patients over the course of several months after HCT (Figure 2 ). Now, 4 and 2 years, respectively, after HCT, both patients remain in excellent health, are leading normal lives and attend regular school.
These are the first reported cases of AR-HIES associated with DOCK8 mutations treated successfully by allogeneic HCT. Our experience indicates that the disorder is completely curable by this therapeutic approach. Furthermore, the observed sustained control after HCT of chronic viral infections of the skin, characteristic for the disorder, strongly suggests that this unusual susceptibility is not, as one may speculate, due to an undefined abnormality in nonhematopoietic cells related to DOCK8 deficiency but is exclusively the result of the immunodeficiency correctable by HCT. Because of usually grave and poorly controllable infectious complications, which may profoundly affect the quality of life in patients with DOCK8 deficiency, as well as the threat to develop malignancies, consideration of an early treatment by HCT is warranted. In this study, we chose a well-tolerated myeloablative conditioning regimen combining reduced intensity chemotherapy with BMtargeted radioimmunotherapy, using radiolabeled MoAbs. At present, it is open whether complete and sustained donor cell chimerism, as achieved by this regimen, indeed is required to permanently control all complications of the disorder, which will need more experience in further cases with DOCK8 deficiency treated by HCT. 
